Aidoc and ACC Collaborate on Cardiovascular Care Enhanced by AI

February 29, 2024—Aidoc and the American College of Cardiology (ACC) announced a collaboration for improved cardiovascular care through Aidoc’s artificial intelligence (AI) technology.

Under the collaboration, ACC will review Aidoc’s AI technology to enhance the identification of patients with coronary artery calcification (CAC). Aidoc’s FDA-cleared technology communicates findings to radiologists and enables coordinated, automatic patient follow-up care. Built on Aidoc’s aiOS platform, the technology analyzes and aggregates medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient.

The collaboration is intended to drive enhanced outcomes for patients with incidentally identified CAC by ensuring that all patients receive the most effective follow-up and ACC guideline-concordant treatment.

According to Aidoc and ACC, the organizations will be collaborating on three primary focuses:

• Refining Aidoc’s Solution—Aidoc and ACC will work together to enhance Aidoc’s AI-enabled solution, ensuring seamless engagement of clinical teams, guideline-directed medical therapy, and recommended follow-up. Areas where the organizations will focus on codevelopment include care pathways, notification methods, ambulatory medicine engagement, provider feedback loops, and patient-centric communication.
• Integration of ACC Guidelines—ACC’s Clinical Guidelines for Prevention and Coronary Artery Disease will be integrated into Aidoc’s solution to enhance workflows for clinical teams. These guidelines will serve as the foundation for developing upstream workflows and assisting clinical teams in effectively utilizing Aidoc’s solution.
• Promoting Health Equity—Health equity is at the center of this collaboration. Traditionally, only patients with dedicated primary care physicians or cardiologists have been recipients of CAC screening scans. With the utilization of Aidoc, every patient undergoing a CT scan can have their imaging assessed for the presence of CAC. This initiative aims to expand access to life-saving cardiovascular assessments, potentially identifying coronary artery disease at earlier stages and offering intervention to prevent heart attacks and strokes, and reduce costs for patients, payers, and health systems.

Ami Bhatt, MD, ACC’s Chief Innovation Officer, and Demetri Giannikopoulos, Vice President of Innovation at Aidoc, commented on the collaboration in the press release.

“Our collaboration with Aidoc is aligned with the ACC’s mission to transform cardiovascular care and improve heart health for all,” stated Dr. Bhatt. “These advanced tools that identify coronary artery calcium and communicate potential increased cardiovascular risk are an important advancement in population health.”

Mr. Giannikopoulos added, “Collaborating with the ACC represents a landmark moment in our mission to harness AI’s potential in healthcare. ACC is renowned for its dedication to advancing cardiovascular care globally, and we are honored to work alongside them to elevate clinical management and enable equitable, preventative, state-of-the-art care.”

He continued, “Together, we can revolutionize how coronary artery calcium is detected and treated, profoundly impacting countless patients’ lives. This collaboration is a testament to our shared commitment to pushing the boundaries of medical innovation.”